Compare GPC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPC | PEN |
|---|---|---|
| Founded | 1928 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.9B |
| IPO Year | 1994 | 2015 |
| Metric | GPC | PEN |
|---|---|---|
| Price | $107.22 | $329.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 17 |
| Target Price | $145.67 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 2.1M | 543.5K |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | 0.47 | ★ 4.52 |
| Revenue | ★ $24,300,141,000.00 | $1,403,665,000.00 |
| Revenue This Year | $5.46 | $14.34 |
| Revenue Next Year | $3.80 | $13.71 |
| P/E Ratio | $231.02 | ★ $72.88 |
| Revenue Growth | 3.46 | ★ 17.50 |
| 52 Week Low | $96.08 | $221.26 |
| 52 Week High | $151.57 | $362.41 |
| Indicator | GPC | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 37.63 |
| Support Level | $96.08 | $326.58 |
| Resistance Level | $135.69 | $338.99 |
| Average True Range (ATR) | 2.60 | 2.24 |
| MACD | 1.45 | -0.22 |
| Stochastic Oscillator | 81.81 | 26.14 |
Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.